Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Clorox Co (CLX) vs Cassava Sciences Inc (FLNA) Price & Performance

Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Clorox Co vs Cassava Sciences Inc — how do they compare? Clorox Co trades at $105.72 (market cap $13.09B), while Cassava Sciences Inc trades at $0.94 (market cap $47.75M). The key difference: Clorox Co is far larger — about 274.1× Cassava Sciences Inc's market cap, and Clorox Co pays a 4.62% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

CLXFLNA
Market Cap
$13.09B$47.75M
Sector
Consumer StaplesHealth
52-Week High
$127.16$4.64
52-Week Low
$86.12$0.87
Enterprise Value
$18.47B-$34.93M
Dividend Yield
4.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Clorox Co

Clorox (CLX) trades at $107.70, up 2.43% today, with a bullish technical signal from moving averages but overbought RSI readings. Recent Q2 2026 earnings beat expectations, though Q4 2025 missed. The company maintains solid profitability with a net margin of 8.74% and ROE of 285.64%, but faces high P/B of 145.45. News highlights Q4 sales beat and a dividend increase to $1.25 per share, while inflation and consumer value-seeking pose challenges.

Outlook is mixed: improving market share and strategic initiatives support growth, but inflation and competitive pressures risk margins. Analyst consensus is cautious with a hold-heavy rating and $97.50 price target below current levels. Key risks include supply-chain inflation and weak organic sales, requiring careful monitoring of execution against guidance.

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Returns comparison

Trailing returns across standard periods

About Clorox Co

With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.

Read more on CLX

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA